Funder: Dept. of the Army -- USAMRAA
Due Dates: June 24, 2026: Pre-Application (Preproposal) | September 30, 2026: Full Application | October 6, 2026: End of Application Verification
Funding Amounts: ~$10.08M total; up to $840,000 total costs per award over 2 years; ~12 awards expected
Summary: Supports innovative, high-risk research ideas in ALS drug or therapy discovery, emphasizing translational potential and biomarker development.
Key Information: Two-step process: pre-application (required) and invited full application; clinical trials are not allowed.